Glucose transporter mediation responsible for morphological changes of human epithelial cells on glucose-displayed surfaces

J Biosci Bioeng. 2008 Apr;105(4):319-26. doi: 10.1263/jbb.105.319.

Abstract

Cellular morphology is one of the important factors for coordinating cell signaling. In this study, the morphological variation via glucose transporter (GLUT)-mediated anchoring was investigated in the cultures of human mammary epithelial cells in the presence or absence of insulin on culture surfaces with the changed ratios of d- and l-glucose displayed. With increasing ratio of d-glucose displayed on the surfaces, the cells showed a stretched shape in the culture with 10 mug/cm(3) insulin, reaching the highest extent of cell stretching at 100%d-glucose display, whereas round cells were predominant at 0%d-glucose display. In the absence of insulin, on the other hand, the extent of cell stretching showed a concave profile in terms of the ratio of d-glucose displayed, the extent being highest at 50%d-glucose display. Blocking of integrin alpha(5)beta(1) or GLUTs1 and 4 on the cells using corresponding antibodies revealed that the primary mechanism for cell attachment was based on integrin-mediated binding, and that GLUTs1 and 4 contributed largely to morphological changes of cells. Confocal microscopy further revealed that GLUT4 localization occurred in response to d-glucose display as well as insulin addition. In the absence of insulin, GLUT4 spots were extensively observed in the cell body regardless of whether d-glucose was displayed or not. However, in the presence of insulin, the broad distribution of GLUT4 appeared on the basal and apical sides of cells at 100%d-glucose display, in contrast with its localization only on the apical side of cells at 0%d-glucose display. These results suggest that the quantitative balance between GLUTs on the cytoplasmic membrane and d-glucose displayed on a culture surface determines the cell morphology, as explained by the receptor saturation model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / pharmacology
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology
  • Cell Membrane / metabolism
  • Cell Shape / drug effects
  • Cell Shape / physiology*
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism*
  • Female
  • Glucose / metabolism*
  • Glucose / pharmacology
  • Glucose Transporter Type 1 / antagonists & inhibitors
  • Glucose Transporter Type 1 / metabolism*
  • Glucose Transporter Type 4 / antagonists & inhibitors
  • Glucose Transporter Type 4 / metabolism*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Insulin / pharmacology
  • Integrin alpha5beta1 / antagonists & inhibitors
  • Integrin alpha5beta1 / metabolism
  • Mammary Glands, Human / cytology
  • Mammary Glands, Human / metabolism*
  • Surface Properties
  • Sweetening Agents / pharmacology

Substances

  • Antibodies
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Hypoglycemic Agents
  • Insulin
  • Integrin alpha5beta1
  • SLC2A1 protein, human
  • SLC2A4 protein, human
  • Sweetening Agents
  • Glucose